A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707). This is an ASCO ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...

Calibrating scores of an AI algorithm can help clinicians identify patients with a high risk of developing hypertrophic cardiomyopathy, or HCM ,a type of heart disease, and quantify the risk they face ...

Previously intractable entanglement growth hampered classical simulation of complex quantum systems. Now, estimating output ...

– Researchers at Mount Sinai have enhanced an existing artificial intelligence (AI) algorithm to provide specific numeric probabilities identifying patients at risk for hypertrophic cardiomyopathy ...

AI success depends on whether enterprise data is ready, reachable, and close enough to the workloads that need it. In this eSpeaks episode, Dell Technologies’ Vrashank Jain explains why fragmented ...